In Brief This Week: GenMark Diagnostics; Roche; Vermillion | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics said this week that it has received a medical device manufacturing license for its new Carlsbad, Calif., facility. The firm said that it can now manufacture and distribute all existing and future products from the facility. It also means that GenMark will cease all manufacturing and distribution from its Pasadena, Calif., facility as of the end of March 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.